Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
JAMA Netw Open ; 5(10): e2236053, 2022 10 03.
Artigo em Inglês | MEDLINE | ID: mdl-36219441

RESUMO

Importance: The global impact of COVID-19 has led to an increased need to continuously assess disease surveillance tools. The utility of SARS-CoV-2 serologic tools in determining immunity levels across different age groups and locations in helping to quickly assess the burden of COVID-19 with significant health policy implications is unknown. Objective: To determine the prevalence of SARS-CoV-2 antibodies with respect to the age group and sex of participants. Design, Setting, and Participants: A cross-sectional survey of 4904 individuals across 12 states with high and low COVID-19 disease burden in Nigeria was carried out between June 29 and August 21, 2021. Main Outcomes and Measures: Enzyme-linked immunosorbent assay was used for the detection of specific SARS-CoV-2 immunoglobulin G and immunoglobulin M antibodies, such as the nucleocapsid protein-NCP and spike protein S1. Interviewer-administered questionnaires provided information on participants' history of disease and associated risk factors. Results: A total of 4904 individuals participated in the study (3033 were female [61.8%]; mean [SD] age, 26.7 [6.51] years). A high seroprevalence of SARS-CoV-2 (78.9%) was obtained. Seropositivity was consistent across the states surveyed, ranging from 69.8% in Lagos to 87.7% in Borno. There was no association between sex and seropositivity (female, 2414 [79.6%]; male, 1456 [77.8%]; P = .61); however, an association was noted between age and seropositivity, with the peak prevalence observed in participants aged 15 to 19 years (616 [83.6%]; P = .001). Similarly, loss of appetite (751 [82.3%]; P = .04) and smell (309 [84.4%]; P = .01) were associated with seropositivity. Conclusions and Relevance: In this cross-sectional study, a high SARS-CoV-2 seroprevalence was obtained among the study population during the low level of vaccination at the time of the survey. Thus, there is a need for both an efficacy and antibody neutralization test study to ascertain the efficacy of the antibody detected and the potential for herd immunity in Nigeria.


Assuntos
COVID-19 , SARS-CoV-2 , Adulto , COVID-19/epidemiologia , Efeitos Psicossociais da Doença , Estudos Transversais , Feminino , Humanos , Imunoglobulina G , Imunoglobulina M , Masculino , Nigéria/epidemiologia , Proteínas do Nucleocapsídeo , Estudos Soroepidemiológicos , Glicoproteína da Espícula de Coronavírus
2.
Glob J Health Sci ; 5(3): 34-41, 2013 Jan 29.
Artigo em Inglês | MEDLINE | ID: mdl-23618473

RESUMO

Reported maternal and child health (MCH) outcomes in Nigeria are amongst the worst in the world, with Nigeria second only to India in the number of maternal deaths. At the national level, maternal mortality ratios (MMRs) are estimated at 630 deaths per 100,000 live births (LBs) but vary from as low as 370 deaths per 100,000 LBs in the southern states to over 1,000 deaths per 100,000 LBs in the northern states. We report findings from a performance based financing (PBF) pilot study in Yobe State, northern Nigeria aimed at improving MCH outcomes as part of efforts to find strategies aimed at accelerating attainment of Millennium Development Goals for MCH. Results show that the demand-side PBF led to increased utilization of key MCH services (antenatal care and skilled delivery) but had no significant effect on completion of child immunization using measles as a proxy indicator. We discuss these results within the context of PBF schemes and the need for a careful consideration of all the critical processes and risks associated with demand-side PBF schemes in improving MCH outcomes in the study area and similar settings.


Assuntos
Serviços de Saúde da Criança/normas , Serviços de Saúde Materna/normas , Centros de Saúde Materno-Infantil/normas , Serviços de Saúde da Criança/economia , Pré-Escolar , Feminino , Humanos , Imunização/estatística & dados numéricos , Serviços de Saúde Materna/economia , Centros de Saúde Materno-Infantil/economia , Vacina contra Sarampo , Nigéria , Projetos Piloto , Gravidez , Estudos Prospectivos
3.
Afr J Reprod Health ; 17(4): 107-17, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24558787

RESUMO

Access to quality reproductive health and family planning services remain poor in Nigeria. We present results on family planning awareness and use from a survey of 3,080 women (age 15-49 years) in Jigawa, Katsina, Yobe, and Zamfara States. About 43.0% had heard of any method of contraception whereas 36.6% had heard of any modern method. Overall, 7.0% of all currently married women reported ever using a method of contraception; 4.4% used a modern method and 2.9% used a traditional method. Only 1.3% of women in union (currently married or cohabiting) used modern contraception methods at the time of the survey; 1.3% of women in union used traditional methods. Unmet need for family planning was 10.3%. Low family planning use in the presence of low awareness and low felt need suggests, among other things, a need to increase awareness and uptake and make family planning commodities available.


Assuntos
Serviços de Planejamento Familiar , Conhecimentos, Atitudes e Prática em Saúde , Necessidades e Demandas de Serviços de Saúde , Serviços de Saúde Rural , Adolescente , Adulto , Anticoncepção/métodos , Anticoncepção/estatística & dados numéricos , Comportamento Contraceptivo , Estudos Transversais , Serviços de Planejamento Familiar/estatística & dados numéricos , Feminino , Inquéritos Epidemiológicos , Humanos , Bem-Estar Materno , Pessoa de Meia-Idade , Nigéria , Serviços de Saúde Rural/estatística & dados numéricos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA